Detalles de la búsqueda
1.
Discovery of CDK5 Inhibitors through Structure-Guided Approach.
ACS Med Chem Lett
; 10(5): 786-791, 2019 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31098000
2.
Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity.
Med Chem
; 15(6): 602-623, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30569866
3.
A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitors.
Future Med Chem
; 9(13): 1495-1506, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28795589
4.
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation.
J Med Chem
; 60(5): 1892-1915, 2017 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28156111
5.
Targeting CDK9: a promising therapeutic opportunity in prostate cancer.
Endocr Relat Cancer
; 23(12): T211-T226, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27582311
Resultados
1 -
5
de 5
1
Próxima >
>>